Remote exercise program to improve blood sugar control and fitness in adults with type 2 diabetes
Official title: A 12 Weeks Clinical Trail to Evaluate the Effect of Remote Exercise Intervention on Blood Glucose Control and Physical Fitness in T2DM Patients
Run by Sichuan Academy of Medical Sciences · NCT07676773 · Data updated 2026-11-12
A remote 12‑week exercise program plus health education is tested in adults with type 2 diabetes to see if it improves blood sugar control and physical fitness.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 69 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Sichuan Academy of Medical Sciences Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | August 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | June 30, 2026 |
| Trial ID | NCT07676773 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–69 with newly diagnosed type 2 diabetes (≤5 years), HbA1c 6.5–7.0%, not on antidiabetic medications, and suitable for remote exercise participation.
✕Probably not a fit
Individuals with diabetes requiring medications or with contraindications to exercise or high exercise risk may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares a remote exercise intervention plus health education to health education alone over 12 weeks in adults aged 40-69 with type 2 diabetes. Participants in the intervention group perform 5–7 weekly sessions of walking, running, aerobic exercise, and swimming, with progressive intensity based on VO2R, plus resistance training 2–3 times weekly; the control group receives equivalent health education but without the structured remote exercise. Heart rate and perceived exertion are monitored, and sessions include warm-up and cooldown. Eligibility requires recent diabetes diagnosis (≤5 years), HbA1c 6.5–7.0%, and no antidiabetic medications, among other safety criteria. The study aims to determine whether remote, structured exercise can better improve glycemic control and cardio-respiratory fitness than education alone.
Why it matters
Potential benefit: If successful, participants may achieve better blood sugar control and improved fitness with a remotely guided exercise program.
How similar studies have gone: Prior studies suggest that remote or home-based exercise programs can improve glycemic outcomes and fitness, though results vary by population and protocol.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: (1) Both gender, age from 40 to 69 years old. (2) Meeting the diagnostic criteria for type 2 diabetes in China. (3) HbA1c is within 6.5%-7 .0% and no medication is taken. (4) Newly diagnosed with diabetes or the duration of the disease is no more than 5 years. (5) Possessing general exercise capacity and no obvious diseases in the muscle and osteoarticular systems. (6) The exercise risk is evaluated as medium or low risk through the PAR-Q+ questionnaire. (7) No contraindications to exercise tests. (8) Willing to adopt intensifed lifestyle intervention and complete the entire research process. Exclusion Criteria: (1) T1DM patients, autoimmune diabetes and special types of diabetes, including hypercortisolism, growth hormone tumor, glucagonoma and some special types of diabetes caused by genetic factors; (2) pregnant or lactating women; (3) regular use of antidiabetic drugs or insulin in the past three months; (4) fasting blood glucose level \> 16.7 mmol/L; (5) recurrent hypoglycemia; (6) a history of acute diabetic complications, including diabetic ketoacidosis, hyperosmolar hyperglycemia, and lactic acidosis; (7) a history of severe chronic microvascular or macrovascular complications; (8) diseases that may be exacerbated by exercise or impair exercise efciency, such as uncontrolled hypertension, hyperthyroidism, osteoarthritis or hypokalemia; (9) unable to use smart phones or wearable smart devices independently; (10) communication or motor dysfunction; (11) Patients with severe chronic diseases could not participate in the study.
Where it's running
-
Sichuan Provinvial People's HSichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital( SAMS&SPPH,Affiliated Hospital of UESTC)ospital
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Wanjing Chen, MPH(Master of Public Health)
- Email: 270746867@qq.com
- Phone: 0086 13980605563
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Occupation-based lifestyle program for adults with type 2 diabetes
A online program tests whether an occupation-focused lifestyle plan helps adults with type 2 diabetes manage daily routines and feel better in life.
-
Downhill walking training for type 2 diabetes
Researchers compare 8 weeks of downhill walking to level-ground walking in adults with type 2 diabetes to see which more improves walking ability and muscle and heart responses.
-
Normast 3 for adults with diabetic polyneuropathy
A 12-week trial will test whether Normast 3 helps reduce nerve pain in adults with diabetic polyneuropathy compared with a placebo.
-
Family-based wellness coaching to prevent type 2 diabetes in Peel
A family-focused wellness coaching program is being tested to see if it can reduce diabetes risk for South Asian and Black African/Caribbean families in Peel, Ontario.
-
Semaglutide Depot in Type 2 Diabetes: Safety, Tolerability, and How It Works
This study tests a long-acting form of semaglutide given every four weeks to adults with type 2 diabetes to see if it is safe and helps control blood sugar and weight.
-
Endothelial progenitor cell dysfunction and inflammation in heart and blood vessel problems of type 2 diabetes
This project will test whether endothelial progenitor cells from adults with type 2 diabetes — with or without cardiovascular complications — have signaling and inflammation-related defects and whether boosting eNOS in those cells improves their repair function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.